Loading...
- v3.6.1.781iOS
2025 Edition Content Update
- v3.6.1.776Android
2025 Edition Content Update
- v3.5.0.767iOS
Content update
- v3.4.1.748iOS
Content update
- v3.3.0.712iOS
Added audio pronunciations
- v3.2.2.691iOS
Updated UI New notes feature Added news feed Provides second free trial for returning users
- v3.1.3.617iOS
Updated UI New notes feature Added news feed
- v3.0.1.520iOS
Framework update
- v2.6.3.439iOS
Updated Mailchimp config
- v2.6.2.437iOS
Bug fixes made to Universal Links
- v2.6.0.411iOS
Latest data update bundled.
- v2.5.1.333iOS
2018 content update Minor styling improvements
- v2.4.2.299iOS
New implementation for 30-day free trial
- v2.3.0.272iOS
Improved user feedback
- v2.2.1.251iOS
Updated analytics
- v2.1.1.240iOS
- Bundled updated data - Updated icon, splash screen and styling
- v1.2.1.112iOS
New drug entries: albiglutide (Tanzeum), apremilast (Otezla), dalbavancin (Dalvance), dapagliflozin (Farxiga), dulaglutide (Trulicity), empagliflozin (Jardiance), eslicarbazepine acetate (Aptiom), ferric citrate (Auryxia), insulin, inhaled (rapid acting) (Afrezza), naloxegol (Movantik), olodaterol (Striverdi Respimat), omega 3-carboxylic acids (Epanova), oritavancin (Orbactiv), sucroferric oxyhydroxide (Velphoro), suvorexant (Belsomra), tedizolid (Sivextro), umeclidinium (Incruse Ellipta), vedolizumab (Entyvio), and vorapaxar (Zontivity).
- v1.0.6.28iOS
Various minor bug fixes and performance improvements